Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties.

[1]  M. Perretti,et al.  Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities. , 2007, Journal of medicinal chemistry.

[2]  C. Serhan.  Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. , 2007, Annual review of immunology.

[3]  Jennifer E. Golden,et al.  Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents. , 2006, Bioorganic & medicinal chemistry letters.

[4]  John Savill,et al.  Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.

[5]  J. Wallace,et al.  Lipoxins in gastric mucosal health & disease , 2005 .

[6]  J. Uddin,et al.  Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[7]  J. Parkinson,et al.  Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogs. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[8]  B. Levy.  Lipoxins and lipoxin analogs in asthma. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[9]  A. Kantarcı,et al.  Lipoxin signaling in neutrophils and their role in periodontal disease. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[10]  K. Gronert.  Lipoxins in the eye and their role in wound healing. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[11]  S. Sodin-Semrl,et al.  Lipoxin A4 biology in the human synovium. Role of the ALX signaling pathways in modulation of inflammatory arthritis. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[12]  J. Uddin,et al.  Cystic fibrosis and lipoxins. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[13]  C. Serhan.  Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[14]  D. Gilroy,et al.  The role of aspirin-triggered lipoxins in the mechanism of action of aspirin. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[15]  C. Serhan,et al.  Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[16]  J. Parkinson,et al.  A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Ridker,et al.  Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Serhan,et al.  Lipoxins and novel 15‐epi‐lipoxin analogs display potent anti‐inflammatory actions after oral administration , 2004, British journal of pharmacology.

[19]  Adriano G. Rossi,et al.  Inflammatory Resolution: new opportunities for drug discovery , 2004, Nature Reviews Drug Discovery.

[20]  C. Godson,et al.  Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease. , 2004, Kidney international.

[21]  J. Uddin,et al.  Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway , 2004, Nature Immunology.

[22]  A. Schottelius,et al.  Novel 3-oxa lipoxin A4 analogues with enhanced chemical and metabolic stability have anti-inflammatory activity in vivo. , 2004, Journal of medicinal chemistry.

[23]  C. Clish,et al.  Reduced Inflammation and Tissue Damage in Transgenic Rabbits Overexpressing 15-Lipoxygenase and Endogenous Anti-inflammatory Lipid Mediators 1 , 2003, The Journal of Immunology.

[24]  C. Serhan,et al.  Aspirin-Triggered Lipoxin A4 and B4 Analogs Block Extracellular Signal-Regulated Kinase-Dependent TNF-α Secretion from Human T Cells 1 , 2003, The Journal of Immunology.

[25]  Christophe Dugave,et al.  Cis-trans isomerization of organic molecules and biomolecules: implications and applications. , 2003, Chemical reviews.

[26]  C. Serhan,et al.  Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells , 2003, The Journal of Biological Chemistry.

[27]  R. Flower.  The development of COX2 inhibitors , 2003, Nature Reviews Drug Discovery.

[28]  K. Asadullah,et al.  An Aspirin-Triggered Lipoxin A4 Stable Analog Displays a Unique Topical Anti-Inflammatory Profile , 2002, The Journal of Immunology.

[29]  Sambasivarao Kotha,et al.  Recent applications of the Suzuki–Miyaura cross-coupling reaction in organic synthesis , 2002 .

[30]  T. Lawrence,et al.  Anti-inflammatory lipid mediators and insights into the resolution of inflammation , 2002, Nature Reviews Immunology.

[31]  Eugene Y. Kim,et al.  Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4 , 2002, Nature Medicine.

[32]  C. Serhan.  Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. , 2002, Prostaglandins & other lipid mediators.

[33]  A. Young,et al.  Lipoxin A4 Analogs Attenuate Induction of Intestinal Epithelial Proinflammatory Gene Expression and Reduce the Severity of Dextran Sodium Sulfate-Induced Colitis1 , 2002, The Journal of Immunology.

[34]  O. Levy,et al.  Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C. Funk,et al.  Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.

[36]  A. Mori,et al.  Mizoroki-Heck type reaction of organoboron reagents with alkenes and alkynes. A Pd(II)-catalyzed pathway with Cu(OAc)2 as an oxidant. , 2001, Organic letters.

[37]  P. Macmathuna,et al.  Lipoxin A4 and Aspirin-Triggered 15-Epi-Lipoxin A4 Antagonize TNF-α-Stimulated Neutrophil-Enterocyte Interactions In Vitro and Attenuate TNF-α-Induced Chemokine Release and Colonocyte Apoptosis in Human Intestinal Mucosa Ex Vivo1 , 2001, The Journal of Immunology.

[38]  B. Levy,et al.  Oxidoreductases in Lipoxin A4 Metabolic Inactivation , 2000, The Journal of Biological Chemistry.

[39]  C. Clish,et al.  Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo , 1999 .

[40]  S. Kurozumi,et al.  Palladium-catalyzed coupling reactions of bromobenzaldehydes with 3,4-di(tert-butyldimethylsilyloxy)-1-alkene to (3,4-dihydroxyalkenyl)benzaldehydes in the synthesis of lipoxin analogues , 1998 .

[41]  C. Clish,et al.  Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. , 1998, The Journal of clinical investigation.

[42]  T. Takano,et al.  Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors , 1997, The Journal of experimental medicine.

[43]  T. Jeffery.  ON THE EFFICIENCY OF TETRAALKYLAMMONIUM SALTS IN HECK TYPE REACTIONS , 1996 .

[44]  N. Petasis,et al.  Mild conversion of alkenyl boronic acids to alkenyl halides with halosuccinimides , 1996 .

[45]  I. Akritopoulou‐Zanze,et al.  Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. , 1995, Biochemistry.

[46]  N. Miyaura,et al.  Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters , 1995 .

[47]  Norio Miyaura,et al.  Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds , 1995 .

[48]  C. Serhan,et al.  Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[49]  C. Serhan,et al.  Lipoxin A4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products. , 1993, Biochemistry.

[50]  N. Petasis,et al.  Titanium-mediated carbonyl olefinations. 1. Methylenations of carbonyl compounds with dimethyltitanocene , 1990 .

[51]  R. Soundararajan,et al.  Hydroboration with boron halides and trialkylsilanes , 1990 .

[52]  S. Dahlén,et al.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. , 1987, Science.

[53]  K. Takai,et al.  Simple and selective method for RCHO → (E)-RCH=CHX conversion by means of a CHX3-CrCl2 system , 1986 .